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see online article: S1 (table) all linkS are aCtive in the online pdf organisms to cell death or cancer in mammalian species 1 . DNA damage-induced mutation is an extensively documented route to mutagenesis for replicating cells. This is caused by DNA polymerases encountering damaged bases and inserting a noncomplementary nucleotide opposite the lesion that gives rise to a permanent and heritable change in the DNA sequence 2, 3 . This replication-centric model for the initiation of mutagenesis has provided a plethora of information for understanding major routes of mutagenesis for organisms existing under conditions of cell growth and division and has contributed substantially to our understanding of a host of biological events, including the origin of genetic variability, evolution and the development of cancer 4, 5 . However, the majority of cells living outside the artificial, growth factor-rich environment of a laboratory do not undergo continuous cycles of replication and growth but are instead more likely to exist in a non-proliferative or slow-growing state 6 . For example, several organs of multicellular organisms, such as the heart or brain, are comprised primarily of non-dividing cells, the lifespan of which is limited by functional degeneration of their normal physiology. Therefore, it follows that a large proportion of an organism's tissues that are exposed to exogenous and endogenous DNA damaging agents are likely to be quiescent or slowly replicating cells, and these exposed cells are probably the origin of some tumours. Therefore, the physiological maintenance of cells and organisms is likely to be largely dependent on the fidelity of both transcription and translation.
There are numerous possible pathways for generating erroneous proteins that do not involve DNA replication (FIG. 1) . At the level of translation, errors can occur through incorrect amino acid incorporation, slippage of the translational machinery or absence of tRNA modifications resulting in misreading of the mRNA 7 . Together, these errors occur once for every 1,000 to 10,000 codons translated 8 , which renders synthesis of a functional protein from an mRNA noticeably error prone. Nonetheless, lapses in translational fidelity or post-translational processing can functionally alter proteins and possibly change the physiology of the cell 9, 10 , which could be crucial for cancer initiation or progression 11 . At the level of transcription, some damaged ribonucleotides with altered pairing specificities can be incorporated into the nascent mRNA by RNA polymerases (RNAPs), thus leading to a mutant transcript that is translated into erroneous proteins 12 .
Another possibility is direct damage to the transcript itself. In this case, damaged ribonucleotides can lead to altered specificities of codon-anticodon recognition such that incorrect amino acids can be incorporated. Direct damage to the transcript has been proposed to explain the aetiology of some human diseases, including neurodegenerative syndromes and the development of several types of cancer [13] [14] [15] . In addition, RNAPs may also misincorporate ribonucleotides
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Abstract | The majority of human cells do not multiply continuously but are quiescent or slow-replicating and devote a large part of their energy to transcription. When DNA damage in the transcribed strand of an active gene is bypassed by a RNA polymerase, they can miscode at the damaged site and produce mutant transcripts. This process is known as transcriptional mutagenesis and, as discussed in this Perspective, could lead to the production of mutant proteins and might therefore be important in tumour development.
Nearly every aspect of cellular behaviour and properties can be altered by the production of erroneous proteins. This situation holds true for cells of every living organism from the simplest prokaryote to the most complex metazoan species. Amino acid substitutions or deletions are causes of changes to protein structure and function that are responsible for a large variety of biological outcomes, which range from conferring an advantageous ability to grow for unicellular Nature Reviews | Cancer per ribo nucleotide) in both prokaryotic and eukaryotic systems [16] [17] [18] . The types of DNA replication-independent pathways that are described above will produce erroneous proteins that have the potential to affect the normal physiology of a cell or to change the cellular phenotype 7, 11 . However, the quantity of erroneous protein produced by these pathways is likely to have only a limited effect on the cell. Indeed, the rare errors caused by these pathways are randomly distributed along an mRNA or protein sequence. Consequently, the amount of erroneous proteins bearing the same amino acid change produced by these randomly targeted errors is expected to be very low. Nonetheless, there is evidence demonstrating that randomly produced, erroneous proteins could have substantial effects 7 . A common example is the decrease of organism fitness when translational fidelity is disrupted by treatment with commonly used antibiotics 19, 20 . Additionally, deficiencies in translational and transcriptional proofreading have the ability to alter cell morphology 21 and lead to severe fitness defects 22, 23 . Another route for the production of erroneous proteins is transcriptional mutagenesis. This process involves the efficient bypass of DNA damage by the transcriptional machinery, accompanied by ribonucleotide misinsertion (FIG. 1) . Transcriptional mutagenesis has the potential to generate substantial levels of mutant transcripts and is likely to produce much greater levels of erroneous proteins compared with the other DNA replicationindependent pathways discussed above. This is because of the inherent targeting of the change in the transcript sequence for every RNAP bypass event, eventually resulting in a pure population of identical, mutant transcripts (FIG. 1) . In turn, each mutant transcript will be translated multiple times and, if the bypass and miscoding event at the site of DNA damage changes a codon specificity, the entire translational output from that transcript population will contain the same amino acid change. Consequently, as long as the initiating damaged deoxy ribonucleotide is not repaired, a largely pure population of mutant proteins (all with the same amino acid sequence) will be present in the cell with the potential to change the cellular phenotype. Transcriptional mutagenesis is a mechanism that can occur in both stem cells and nonstem cells and, thus, may have an important role in the development of several types of cancer.
In this Perspective, we describe transcriptional mutagenesis in quiescent or slowgrowing cells. We then discuss the evidence that transcription can be affected by damage to deoxyribonucleotides in transcribed DNA. This damage is induced by a plethora of agents present in natural environments and is the origin of transcriptional mutagenesis. We also discuss the evidence supporting the involvement of transcriptional mutagenesis in tumour development 24 .
How to study transcriptional mutagenesis Many studies investigating transcriptional mutagenesis have been carried out with defined, in vitro transcription systems containing purified components and/or various types of cell extracts necessary for initiation, elongation and termination of transcription on a DNA template. Central to these studies is the availability of transcription templates containing single, well-characterized DNA lesions at defined locations. Although it is theoretically feasible to introduce many different types of DNA damage into transcription templates, such procedures are technically challenging and often result in poor yields of product. New methodologies that result in large quantities of damagecontaining substrates have since been developed 25, 26 . In vitro transcription studies have used bacteriophage, bacterial, yeast and mammalian RNAPs to determine whether such enzymes can bypass DNA lesions or are instead stalled or blocked at such sites. These studies have used both multiple round transcription conditions (template re-utilization or recycling) and single round transcription conditions (one promoter-dependent elongation cycle per template-RNAP elongation complex). In several cases, sequencing analysis has been carried out on transcripts resulting from RNAP bypass of lesions to determine the nature of the incorporationmisincorporation events (TABLE 1) .
Although some lesions that are bypassed by RNAPs are likely to cause transcriptional mutagenesis, it was unknown whether this process would also occur in living cells owing to the simultaneous presence of multiple DNA repair pathways, which might occur instead of RNAP bypass of DNA damage
. Experimental systems devised to address this question in living cells had to meet two requirements 25, [27] [28] [29] . The first was to use a reporter plasmid expressing a protein for which the activity can be biochemically determined. In most studies, a site-specific DNA lesion was positioned in the transcribed strand of the reporter gene such that if the Figure 1 | dna replication-independent production of erroneous proteins. Under normal conditions (a), transcription in the nucleus produces error-free mRNAs that are translated by ribosomes to normal proteins (blue ovals) in the cytoplasm. In some cases (b), lapses in RNA polymerase (RNAP) fidelity can generate aberrant transcripts (yellow circle) that are translated into erroneous proteins (yellow oval). This random, low-frequency production of erroneous proteins can also be caused by lapses in ribosome fidelity. When exposed to a genotoxic agent (c), RNA molecules in a cell may contain various lesions (triangles) that could induce the production of erroneous proteins during translation because of their potentially altered codon-anticodon pairing during tRNA selection. DNA is the other target for genotoxic stress (d). RNAP can bypass numerous unrepaired damaged deoxyribonucleotides on the transcribed strand of a gene (red triangle) that can result in misincorporation events in the transcript sequence (red circles) as long as the DNA damage is not removed by one of the DNA repair pathways. Transcriptional mutagenesis results in the production of a mostly homogenous mutant transcript population, which in turn leads to the production of high levels of erroneous proteins that possess the same mutant sequence, and that could alter the phenotype of the cell. Various DNA polymerases Strong block to replication damage was repaired, the resulting mRNA encoded an inactive protein. However, if the DNA lesion was misread during transcription, a fully active protein was produced and activity could be measured to ascertain the extent of the bypass. The second requirement for these in vivo systems was to ensure that the measured activity of the reporter protein was the result of transcription across the DNA lesion and not permanent fixation of base sequence changes through DNA replication into a heritable mutation. In bacterial systems, cells had to be maintained in a nongrowing state in which transcription, but not DNA replication, is occurring, and this was achieved by the use of growth-inhibiting antibiotics such as novobiocin [29] [30] [31] . In eukaryotic systems, this problem was eliminated by using reporter vectors that are devoid of replication initiation sites [32] [33] [34] .
Mechanistic insights
In quiescent or slow-growing cells, an elongating RNAP is likely to frequently encounter a DNA lesion on the template strand of actively transcribed genes. For example, it is estimated that, in human tissues, levels of abasic sites range from 4,000 per leukocyte genome to 200,000 per liver cell per day 35 . Additionally, the estimated steady-state level of 8-oxoguanine (8-oxoG), a lesion induced by oxidative stress, is approximately 1,000 per cell per day in normal tissues and up to 100,000 per cancer cell per day 36 . When an RNAP encounters these lesions, either blockage of RNAP elongation or bypass of the lesion by the transcriptional machinery could occur. Stalling or blockage of the RNAP at a lesion site activates the transcription-coupled repair (TCR) pathway
, which is a sub-pathway of the nucleotide excision repair (NER) pathway that is dedicated to the repair of DNA damage in the transcribed strand of a gene (reviewed in REFs 37, 38) . However, not all DNA lesions stall or block an elongating transcription complex, and when such lesions modify pairing properties, they are readily bypassed by RNAP and can cause ribonucleotide misincorporation, which can result in the generation of mutant transcripts with a specific codon-specificity change (reviewed in REFs 39, 40) . The case of uracil. RNAPs from different organisms, including mammals, are able to bypass many types of non-bulky DNA lesions that are typically substrates of the base excision repair (BER) pathway, including uracil, which is the product of spontaneous deamination of cytosine [41] [42] [43] [44] [45] [46] . When uracil is present on a transcribed strand, prokaryotic RNAPs always insert adenine into the transcript [42] [43] [44] [45] [46] , whereas mammalian RNAPII inserts either adenine or guanine into the transcripts 47 . This partially reduces the ability of uracil to cause transcriptional mutagenesis in mammalian cells, as guanine is not mutagenic in this context. The first published study of transcriptional mutagenesis in living cells confirmed that bacterial RNAP inserted an adenine opposite a uracil present in the transcribed strand of a luciferase reporter gene 29 , an observation that was confirmed by further studies 30, 31 .
Oxidative base damage. Reactive oxygen species (ROS), including the O 2 •-and OH
• radicals and H 2 O 2 , may be the most important genotoxic agents because of their ubiquitous and continuous production as by-products of respiration 48 . In mammalian cells, they have been implicated in the aetiology of a variety of pathophysiologies, including ageing and various cancers 49 . Genotoxicity of ROS results from their reaction with DNA to produce a plethora of lesions that are repaired primarily by the BER pathway in both bacteria and eukaryotes 50 . Several oxidative lesions were tested for their ability to induce transcriptional mutagenesis, including 5-hydroxyuracil 51 , thymine glycol [51] [52] [53] , 5-guanidino-4-nitroimidazole 54 , dihydrouracil 24, 42 and 8-oxoG 41, 43, 55 . In some cases, certain types of oxidative damage do not cause transcriptional mutagenesis. For example, transcript sequencing has revealed human RNAPII correctly incorporates adenine opposite 5-hydroxyuracil and thymine glycol 51 , and cytosine is correctly incorporated opposite guanidino-4-nitroimidazole 54 . However, other oxidative DNA lesions are prone to transcriptional mutagenesis, such as dihydrouracil, which is caused by damage to cytosine and primarily directs the addition of adenine 24, 42 . Furthermore, it was shown in vitro that bypass of 8-oxoG by prokaryotic RNAPs incorrectly directs the incorporation of an adenine only approximately half of the time, and otherwise correctly incorporates cytosine 43, 55 . However, when RNAPII from HeLa cells is used, this adenine/cytosine ratio seems to depend on the concentration of ribonucleoside triphosphates (NTPs) used in the reaction mixture 41 . Transcriptional mutagenesis studies using a luciferase reporter gene in Escherichia coli also confirmed that 8-oxoG was able to instruct the correct incorporation of cytosine and the misincorporation of adenine during transcription, but a single ribonucleotide deletion corresponding to the lesion site was also identified in approximately one-quarter of the mRNA population 30 . In mammalian cells, two studies were carried out with vectors containing one 8-oxoG at a defined position on the transcribed strand of the reporter gene. As with bacterial RNAP, mammalian RNAPII incorporates either cytosine, adenine or no ribonucleotide opposite the lesion 32, 34 . The ratio of each incorporation event was shown to vary depending on the sequence flanking the 8-oxoG, on the relative distance between the lesion and the promoter, on the nature of the deoxyribonucleotide opposite the lesion in the non-transcribed strand and, most importantly, on the availability of the DNA repair pathways that are capable of removing 8-oxoG from the DNA 32, 34 . Structure-function analysis provided insight into the structural basis for how readily bypassed putative carcinogenic DNA lesions, such as 8-oxoG 56 , can cause transcriptional mutagenesis. Using yeast RNAPII, it was shown that misincorporation of adenine forms a Hoogsteen base pair at the active centre and that, to achieve this pairing, 8-oxoG must adopt the syn conformation 57 . Similar to RNAPII, high-fidelity DNA polymerases incorporate cytosine and adenine to various extents during replication opposite 8-oxoG [58] [59] [60] [61] [62] [63] (TABLE 1) , and cytosine incorporation occurs with the same type of nucleotide pairing and conformation 64, 65 .
DNA helix-distorting damage. The majority of transcriptional mutagenesis studies carried out to date involve the elucidation of misincorporation events occurring during transcription across lesions that do not cause substantial distortion to the DNA backbone and are repaired primarily by the BER pathway. By contrast, almost all bulky, distortive lesions (which are primarily repaired by the NER pathway) represent strong blocks to replication-associated DNA polymerases and elongating RNAPs in vitro, and they are likely to elicit TCR 37, 38 
. However, in NER-deficient human cells, two helixdistorting lesions, ultraviolet (Uv) radiationinduced cyclobutane pyrimidine dimers (CPDs) and the oxidative base damage 8,5′-cyclo-2′-deoxyadenosine (cyclo-dA), are strong but incomplete blocks to transcription 66 . Characterization of the transcripts produced from the RNAPII bypass of these lesions in vivo has led to the identification of new types of transcriptional mutagenesis events. When bypassed, cyclo-dA induces the incorporation of uracil opposite the lesion followed by misincorporation of adenine opposite the next deoxyribonucleotide downstream (that is, 5′) to the lesion 33 (5′A ; TABLE 1 ). Additionally, rare transcripts containing multiple ribonucleotide deletions were identified in transcripts resulting from the bypass of cyclo-dA and CPDs 33 . Although such mutant transcripts represent a small proportion of the total mRNA population, they occurred in cells from patients with cancer-prone or developmental disorderassociated DNA repair syndromes (such as xeroderma pigmentosum and Cockayne syndrome, respectively), thus raising the possibility of a link between transcriptional mutagenesis and the aetiology of these syndromes.
Another DNA helix-distorting lesion that was studied for its ability to induce transcriptional mutagenesis is the 1,2-guanineguanine (1,2-d(GpG)) intrastrand crosslink, which is formed by the anticancer drug cisplatin. When artificially placed on the template strand in proximity to the active site of RNAPII, this lesion induces the misincorporation of adenine opposite the first guanine, whereas cytosine is correctly incorporated opposite the second, 5′ guanine 67 . However, transcriptional mutagenesis caused by cisplatin adducts might not be observed in living cells because the artificial conditions used for this study are not likely to occur in vivo. 17, 71 . Whereas the adenine adducts direct the misincorporation of either adenine or guanine 17 , sequence analysis of bypassed guanine adducts indicates that non-mutagenic cytosine is inserted 71 .
However, this study also demonstrated that truncated transcripts resulting from RNAP arrest at this lesion contained mutagenic ribonucleotide insertions, indicating that, in some cases, RNAP arrest may result from the structural strain of incorrect base pairing opposite the lesion site. The adducts guanine C-8 aminofluorene (AF-G) and guanine C-8 acetylaminofluorene (AAF-G) are also subject to some level of bypass, with the bulkier AAF-G moiety being more effective at blocking the transcription machinery 55 . Both lesions were found not to induce transcriptional mutagenesis as they direct the correct incorporation of cytosine 55 .
Abasic sites, strand breaks and other DNA repair intermediates. Deficiency in one or several DNA repair pathways is a hallmark feature of most cancerous or precancerous cells 4 . Consequently, the presence of repair intermediates (such as abasic sites or single-strand breaks and gaps) in the transcribed strand of a gene might be more frequent in these cells. Abasic sites, as well as the abasic site analogue tetrahydrofuran, are efficiently bypassed by prokaryotic RNAPs 31, 44, 46, 55 . Adenine was most often incorporated opposite a template abasic site, although a small fraction of guanine was incorporated opposite tetrahydrofuran by T7 RNAP 44, 46, 55 . This pattern of insertion events could be highly transcriptionally mutagenic given that depurination of guanine residues is the most frequent event leading to the spontaneous formation of abasic sites 72 . However, the potential to elicit transcriptional mutagenesis by these lesions might be reduced in mammalian cells, as purified HeLa RNAPII preferentially incorporates the addition of cytosine opposite abasic sites 41 . Remarkably, single-strand breaks and gaps have also been demonstrated to be bypassed by prokaryotic RNAPs 45, 73, 74 . This event occurs with varying levels of efficiency and depends on the size of the template gap, the flanking DNA termini and the type of RNAP involved. Small gaps are bypassed with higher efficiency than larger gaps 74 , termini containing hydroxyl groups are negotiated better than those containing phosphates or modified sugars 45 and bacteriophage polymerases are more efficient at bypassing damage than RNAP from E. coli 73 . Analysis of the transcripts generated by transcription across single-strand gaps indicates that they contain correctly templated ribonucleotides on both sides of the gap, but that the site of the gap
Box 1 | Transcriptional mutagenesis versus transcription-coupled repair
It is well documented that the RNA polymerase II (RNAPII) elongation complex arrests at sites of DNA damage and that this represents a strong signal for apoptosis [83] [84] [85] . Therefore, cells have evolved a specialized mechanism called transcription-coupled repair (TCR), which involves the hierarchical recruitment of several proteins that remove transcription-blocking DNA lesions from the genome 37, 38 . Transcriptional mutagenesis and TCR are therefore competing processes. A major issue is to determine the proportion of specific DNA lesions that can be bypassed by RNAPII (potentially causing transcriptional mutagenesis) and the proportion that is repaired by TCR. This has been the subject of a number of studies addressing the fate of RNAPII encountering an oxidative DNA lesion such as 8-oxoguanine (8-oxoG). TCR was originally documented for DNA damage induced by ultraviolet (UV) radiation, but it may also act in a transcription-dependent manner to repair oxidative DNA damage in Escherichia coli 30 . Additionally, it was shown that cells from individuals with Cockayne syndrome (CS) were defective for both TCR and the repair of oxidative DNA lesions that could explain the non-cancer-prone mutator phenotype of patients with CS 86 . However, questionable results obtained by a former researcher and presented in key papers addressing this question have been either partly or completely retracted [87] [88] [89] . Nonetheless, a link between repair of oxidative damage and transcription might exist as host cell reactivation of plasmids containing 8-oxoG is defective in cells lacking activity of CSA (also known as ERCC8) or CSB (also known as ERCC6), which are two key proteins involved in TCR 90 . Additionally, after transfection into mouse embryonic fibroblasts, expression of the reporter gene from shuttle vectors containing a single 8-oxoG in the transcribed strand required CSB 91 . However, the same effect was not observed when 8-oxoG was located in a different sequence context and a weaker promoter was used 92 . Moreover, measurements of transcriptional mutagenesis induced by 8-oxoG in different cell lines revealed that the magnitude of erroneous protein expression was the same in both TCR-proficient and TCR-deficient cell lines but was dependent on the sequence context surrounding the lesion 32, 34 . These findings suggest that factors such as promoter strength, sequence context and the position of the lesion with respect to the promoter may influence transcription past a single 8-oxoG by RNAPII.
shows up as a deletion in the transcript (a 1 ribonucleotide deletion for a 1 deoxyribonucleotide gap, a 2 ribonucleotide deletion for a 2 deoxyribonucleotide gap, and so on) 45, 73, 74 . Although in vivo studies brought confirmation of some results obtained in vitro, they also revealed surprising features regarding the occurrence of transcriptional mutagenesis in living cells. In some cases, new, unexpected events were identified by sequencing the transcripts of the reporter gene. Indeed, recent studies in E. coli indicate that there are factors that facilitate RNAP bypass of strand breaks and gaps in vivo 31 . Sequence analysis of the luciferase reporter mRNA produced from the bypass of RNAP across a strand break revealed that adenine is incorporated opposite the gap and no deletion in the transcript was detected 31 , thus leading to the production of mRNA with a change in codon specificity but avoiding the production of mRNA with frameshift mutations.
The expression of erroneous proteins through transcriptional mutagenesis. An important potential physiological consequence of transcriptional mutagenesis is a transient phenotypic change owing to the expression of a large pool of mutant proteins within the cell. It is clear that many DNA lesions have the ability to induce transcriptional mutagenesis and thus initiate a change in biological activity. However, it is likely that, in most cases, the population of erroneous protein has to be sufficiently large to be able to induce such a change. It follows that infrequently bypassed lesions (such as CPDs) should be less capable of eliciting a phenotypic change compared with frequently bypassed lesions (such as 8-oxoG). Thus, to date, all in vivo studies investigating phenotypic changes caused by transcriptional mutagenesis have been conducted with replication-defective DNA constructs containing a single non-distorting lesion in the transcribed (template) strand of a reporter gene.
Using a luciferase transcriptional mutagenesis reporter-based expression system, erroneous transcriptional bypass of uracil, abasic sites or 8-oxoG gave rise to a phenotypic change in both bacterial and mammalian systems [29] [30] [31] [32] . In all of these studies, bypass of the DNA lesion was enhanced by disruption of the genes encoding the major BER proteins responsible for the removal of these lesions in the cells, thereby prolonging the half-life of the DNA damage harboured in the template DNA. Consequently, the phenotypic change was more robust and prolonged over time in the DNA repair-deficient cell lines. These observations are relevant to the potential role of transcriptional mutagenesis in the development of cancer, as several reports demonstrate that individuals expressing hypomorphic alleles of genes encoding proteins that are involved in BER have higher risks of developing different types of cancer [75] [76] [77] . Interestingly, high levels of active luciferase, produced by transcriptional mutagenesis, were detected for up to 7 days following transfection of a vector containing 8-oxoG in DNA repair-proficient cells 32 . Given that luciferase is not a very stable protein -its halflife was estimated to be no more than 4 hours in mammalian cells -transcriptional mutagenesis must therefore continue for a prolonged period of time even in human cells with normal DNA repair capacity.
Tumour development
Activation of ERK phosphorylation following transcriptional mutagenesis. Although informative, luciferase-based studies are not adapted for studying the potential of DNA lesions to cause transcriptional mutagenesis with a biologically relevant outcome. In this regard, replacement of the luciferase gene with a cDNA in which erroneous transcription events can be detected through the translation of an encoded protein that elicits a measurable biological end point represented a major step forward for investigations of transcriptional mutagenesis in living cells. This system was used in mouse embryonic fibroblasts for the oncogene HRAS, in which 8-oxoG replaced guanine at codon 61 (REF. 34 ). Bypass and misinsertion opposite this lesion during transcription would result in the production of the constitutively active (dominant) HRAS-Q61K mutant protein. The occurrence of this transcriptional mutagenesismediated event was followed in different mouse embryonic fibroblasts by the activation of components of the MAPK pathway, including increased ERK phosphorylation. Despite the detection of mutant HRAS transcripts in DNA repair-proficient cells, the extent of transcriptional mutagenesis was not sufficient to induce a detectable increase in ERK phosphorylation. However, in cells lacking 8-oxoG DNA glycosylase (OGG1), the main glycosylase that initiates BER of 8-oxoG lesions, the proportion of mutant HRAS transcripts was elevated four-to fivefold and ERK phosphorylation was readily detected and found to be significantly increased. However, it is currently not known whether such cells are capable of forming tumours in xenografts. Given that most cancer cells are deficient in at least one DNA repair pathway 78 , including BER 79 , these observations strongly suggest that transcriptional mutagenesis could lead to the activation of an oncogenic pathway.
Box 2 | Other biological consequences of transcriptional mutagenesis
In addition to its potential involvement in tumour development, transcriptional mutagenesis may have other consequences for eukaryotic cells. Transcriptional mutagenesis also provides a mechanism for the generation of prions in neuronal cells. If the mutant protein generated by transcriptional mutagenesis is more stable in the β-sheet conformation, this event could allow the generation of adequate levels of protein to promote prion fibre nucleation, subsequently leading to the conversion of normal protein to the prion conformation and causing fibril formation and finally neuronal death 93 . This mechanism of nucleation induced by the transient production of mutant protein can also be used to explain the aetiology of other neurodegenerative syndromes that are characterized by aggregates of misfolded proteins, including Alzheimer's disease and Parkinson's disease. Indeed, mutant forms of amyloid precursor proteins and ubiquitin (UBB) are detected in protein aggregates found in the dystrophic neurites that contribute to the characteristic pathology of Alzheimer's disease (neuritic plaques, neurophil threads and neurofibrillary tangles) but not in brains of individuals without dementia 94 . Mutant proteins were found to originate from mutant mRNAs that were produced in the affected cells, but examination of the genomic DNA failed to reveal any evidence of mutation, so the mutations are presumed to have arisen as errors of transcription 94 . Whether these transcription errors are caused by transcriptional mutagenesis or lapses in RNA polymerase (RNAP) fidelity remains to be established. However, it is well documented that oxidative DNA damage accumulates in ageing brains and that increased levels of oxidized guanine are found in DNA from ventricular cerebrospinal fluid of patients with Alzheimer's disease compared with controls 95 . These increased levels of DNA damage are also correlated with decreased DNA repair capacity 96 . Additionally, when a nucleation-prone mutant protein is produced in a specific neuronal cell, the protein aggregation phenomenon could be detrimental to neighbouring cells. Indeed, the addition of aggregated α-synuclein forms, which are found in neuronal cells from patients with Alzheimer's or Parkinson's disease, to the culture medium of neuroblastoma cells causes apoptosis 93 . These observations strongly suggest that transcriptional mutagenesis could also have an important role in the aetiology of neurodegenerative diseases. Nature Reviews | Cancer Retromutagenesis: a transcriptional mutagenesis-driven switch to growth. The observations outlined above suggest that bypassed carcinogenic lesions could lead to the activation of oncogenic pathways. One key point for this hypothesis is that, as already discussed for 8-oxoG and O 6 mG, the majority of these types of DNA lesion cause the same types of misincorporations during both transcription and replication. In some cases, transcriptional mutagenesisinducing DNA damage can reside in the DNA for a long period of time, leading to the prolonged production of erroneous proteins 32 . It is conceivable that certain mutant proteins (such as HRAS-Q61K) produced by transcriptional mutagenesis activate an oncogenic, proliferative pathway, which promotes re-entry into the cell cycle and increases the chance that the DNA replication machinery will encounter the same lesion that originally caused transcriptional mutagenesis. The deoxyribonucleotide inserted opposite the lesion by DNA polymerases will, in many cases, be equivalent to the one inserted during transcription. Such an event would ensure permanent retention of the growth initiating mutation in one daughter cell, resulting in a heritable change. This process has been termed retromutagenesis 39, 80 (FIG. 2) and can thus initiate a transition from a non-growth state to a growth state that could account for the development of mammalian tumours at the stage at which expansion of an abnormal cell population occurs. For example, as seen with HRAS, transcriptional mutagenesis could lead to the acquisition of alterations to proteins that cause limitless replicative potential, a hallmark of cancer. Furthermore, the production of certain mutant proteins could also perturb signalling pathways that are normally dedicated to responding to anti-growth signals or the induction of apoptosis.
Interestingly, within the database of tumour-associated p53 mutations (see the IARC TP53 mutation database), approximately 5% of tumours are reported to contain two or more base substitutions in TP53 (the gene that encodes p53 in humans). A retrospective analysis of this database by Holmquist and colleagues 81 indicates that most base substitution multiplets arise from a transient, hypermutagenic event in one cell that subsequently proliferated into a clonal tumour. This transient hypermutagenesis of TP53 creates a base substitution -the driver mutation -that arises on the transcribed strand of TP53 and changes the amino acid sequence of p53, whereas the other mutations (termed hitchhikers or passengers) 81 tend to originate in the non-transcribed strand and do not affect the activity of the encoded protein. This strongly suggests that selection acted while the initiating lesion was present in the transcribed strand opposite a non-mutated, non-transcribed strand (FIG. 2) . Accordingly, the most likely scenario for the generation of multiple base substitutions is the transcriptional bypass of a DNA lesion that is located at the site of the driver mutation that induces misincorporation by the RNAP. This transcriptional mutagenesis event generates a transient mutant TP53 mRNA that is translated into mutant p53 protein that would allow the cell to transiently switch to a growth state. Subsequently, if the same DNA lesion is misread during replication, the advantageous driver mutation would be permanently established into the progeny of the cell, together with the other hitchhiker mutations. This retromutagenesis event would then be at the origin of tumours containing multiple TP53 mutations 80 . Figure 2 | the potential role of transcriptional mutagenesis in tumour development. Following genotoxic stress, a DNA lesion (red triangle) can appear on the transcribed strand of a gene, resulting in the production of high levels of erroneous protein by transcriptional mutagenesis (FIG. 1) . The resulting mutant proteins (red ovals) may have the ability to alter the phenotype of the cell in such a way that a growth advantage is conferred, leading to initiation of DNA replication. If left unrepaired, the DNA lesion will subsequently be encountered by the replication machinery and will probably cause similar miscoding during DNA synthesis, which will result in the fixation of the mutation into the genome of one of the replicated progeny (red circle). Subsequent rounds of replication of the mutated chromosome could lead to tumour development. RNAP, RNA polymerase.
Box 3 | biological consequences of transcriptional mutagenesis for prokaryotes
The retromutagenesis mechanism can also be viewed as an environmental adaptation pathway in prokaryotes, as such retromutations would have been 'tested' and selected for conferring a growth advantage as mutant mRNAs before they became heritable mutations. The increased fitness induced by this environmental adaptation is 'cell-selfish' because it is limited to an immediate growth or replication advantage for that host cell in that environment. This cell-selfish mode of evolution can help to confer an immediate growth advantage while minimizing DNA mutational load 80 . Such a process has been proposed to explain adaptive mutagenesis induced by starvation in Escherichia coli, a setting in which mutations arise rapidly and are confined to those that allow the cells to grow 97, 98 . In non-proliferating cells, the contribution of transcriptional mutagenesis to the mutant protein pool, and thus the cellular phenotype, is likely to be much more apparent, especially because the capacities of certain DNA repair pathways are diminished in those conditions 98, 99 . A similar role for transcriptional mutagenesis in bacterial and other haploid unicellular organisms has been proposed for the acquisition of antibiotic resistance in microbial pathogens 31 . P e r s P e c t i v e s conclusions and future perspectives As data are accumulating, it is becoming clearer that transcriptional mutagenesis could have an important role in tumour development and other biological outcomes (BOXEs 2,3) . However, transcriptional mutagenesis should not be considered as the predominant mechanism in tumour initiation. Indeed, the effects of transcriptional mutagenesis are limited by: the half-life of the initiating DNA lesion, which has to be transcribed several times to produce sufficient levels of mutant proteins and has to be replicated to permanently establish the mutation by retromutagenesis; the half-life of the mutated mRNA; and the half-life of the mutated protein. In this regard, transcriptional mutagenesis is more likely to have a role in tumour development of transformed cells where mutations have already occurred. Indeed, if mutations have occurred in one or several genes involved in DNA repair mechanisms, the half-life of DNA lesions in the genome will be extended, leaving more chance for transcriptional mutagenesis to play a part in tumour development. It follows that replicative mutagenesis is likely to be a major culprit in cancer causation, but transcriptional mutagenesis might have an important role in the initiation or the establishment of these mutations, especially through retromutagenesis. It is important to note that either transcriptional or replicative mutagenesis could occur in both stem cell and non-stem cell populations, thus contributing to tumour development in various ways.
Although vector-based analyses of transcriptional mutagenesis are informative, the validation for the role of transcriptional mutagenesis in tumour development remains to be precisely established. The next challenge will be to express a reporter gene (present at one copy per cell) containing a DNA lesion in its transcribed strand and to follow the subsequent phenotypic change(s) that should result from the production of erroneous proteins. One will then have to follow the progeny of a single cell to determine whether cancerous growth can be initiated by the transient expression of oncogenic proteins or the disruption of signalling pathways.
Additionally, a more global approach to investigating transcriptional mutagenesis is now possible with the emergence of new technologies. For example, massively parallel sequencing of cellular mRNA populations 82 could be used to determine the extent of transcriptional mutagenesis in response to various genotoxic agents and in cell types with different DNA repair capacities. Future studies addressing these issues will provide additional insights into the mechanisms and consequences of transcriptional mutagenesis and further establish the role of this process in tumour development.
